|
| EMpagliflozin iMpurity 6 Basic information |
Product Name: | EMpagliflozin iMpurity 6 | Synonyms: | EMpagliflozin iMpurity 6;α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, 2,3,4,6-tetraacetate;(2S,3R,4S,5R,6R)-6-(acetoxymethyl)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl triacetate;(S)-3-(4-(2-chlorobenzyl)phenoxy)tetrahydrofuran | CAS: | 1620758-21-5 | MF: | C32H37ClO12 | MW: | 649.09 | EINECS: | | Product Categories: | | Mol File: | 1620758-21-5.mol | |
| EMpagliflozin iMpurity 6 Chemical Properties |
Boiling point | 679.3±55.0 °C(Predicted) | density | 1.33±0.1 g/cm3(Predicted) |
| EMpagliflozin iMpurity 6 Usage And Synthesis |
Uses | Empagliflozin Tetraacetoxy is an impurity of Empagliflozin, a novel, potent and selective SGLT-2 inhibitor that improves glycaemic control and features of metabolic syndrome in diabetic rats. |
| EMpagliflozin iMpurity 6 Preparation Products And Raw materials |
|